NCT06404554

Brief Summary

Background: Anastomotic stricture significantly impacts patients' quality of life and long-term prognosis. However, current clinical practice lacks accurate tools for predicting anastomotic stricture. This study aimed to develop a nomogram to predict anastomotic stricture in patients with rectal cancer who have undergone anterior resection. Methods: 1542 eligible patients will be recruited for the study. Least absolute shrinkage selection operator (Lasso) analysis will be used to preliminarily select predictors. A prediction model will be constructed using multivariate logistic regression and presented as a nomogram. The performance of the nomogram will be evaluated using receiver operating characteristic (ROC) curves, calibration diagrams, and decision curve analysis (DCA). Internal validation will be conducted by assessing the model's performance on a validation cohort.

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
1,542

participants targeted

Target at P75+ for all trials

Timeline
Completed

Started Jan 2024

Shorter than P25 for all trials

Geographic Reach
1 country

1 active site

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

January 1, 2024

Completed
3 months until next milestone

Primary Completion

Last participant's last visit for primary outcome

March 31, 2024

Completed
1 month until next milestone

Study Completion

Last participant's last visit for all outcomes

April 30, 2024

Completed
5 days until next milestone

First Submitted

Initial submission to the registry

May 5, 2024

Completed
3 days until next milestone

First Posted

Study publicly available on registry

May 8, 2024

Completed
Last Updated

May 8, 2024

Status Verified

May 1, 2024

Enrollment Period

3 months

First QC Date

May 5, 2024

Last Update Submit

May 5, 2024

Conditions

Keywords

nomogramrectal canceranastomotic stricture

Outcome Measures

Primary Outcomes (2)

  • patients with anastomotic stricture

    Within six months after rectal cancer surgery, the patient was diagnosed with benign stricture of the rectal anastomosis

    up to six months

  • patients without anastomotic stricture

    Within six months after rectal cancer surgery, the patient was not diagnosed with benign stricture of the rectal anastomosis

    up to six months

Study Arms (2)

patients with anastomotic stricture

without any intervention, patients diagnose as anastomotic stricture after rectal cancer surgery

Other: without any intervention

patients without anastomotic stricture

without any intervention, patients does not diagnose as anastomotic stricture after rectal cancer surgery

Other: without any intervention

Interventions

without any intervention

patients with anastomotic stricturepatients without anastomotic stricture

Eligibility Criteria

Age18 Years - 80 Years
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)
Sampling MethodProbability Sample
Study Population

patients who underwent anterior resection for rectal cancer at the Department of Gastrointestinal Surgery, Northern Jiangsu People's Hospital. All participants received radical treatment consistent with total mesorectal excision (TME) principles

You may qualify if:

  • pathological confirmation of rectal cancer;
  • eligibility for surgical intervention;
  • undergoing first rectal cancer surgery;
  • acquisition of written informed consent from patients and their families;
  • no history of hypertrophic scar or allergic predispositions.

You may not qualify if:

  • absence of postoperative follow-up or anastomosis details;
  • patients subjected to Hartmann or Miles procedures;
  • emergency surgery candidates due to conditions like perforation or obstruction;
  • diagnosis of multiple primary malignancies;
  • intraoperative discovery of widespread implant metastases within the abdominal cavity;
  • severe comorbidities;
  • anastomotic recurrence of rectal cancer;
  • patients who had undergone stapled hemorrhoidopexy

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Yifan Cheng

Yangzhou, Jiangsu, 225000, China

Location

MeSH Terms

Conditions

Colorectal NeoplasmsRectal Neoplasms

Condition Hierarchy (Ancestors)

Intestinal NeoplasmsGastrointestinal NeoplasmsDigestive System NeoplasmsNeoplasms by SiteNeoplasmsDigestive System DiseasesGastrointestinal DiseasesColonic DiseasesIntestinal DiseasesRectal Diseases

Study Design

Study Type
observational
Observational Model
COHORT
Time Perspective
RETROSPECTIVE
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Clinical Professor

Study Record Dates

First Submitted

May 5, 2024

First Posted

May 8, 2024

Study Start

January 1, 2024

Primary Completion

March 31, 2024

Study Completion

April 30, 2024

Last Updated

May 8, 2024

Record last verified: 2024-05

Data Sharing

IPD Sharing
Will not share

Locations